Sidley Austin represented BigHat Biosciences in the transaction. BigHat Biosciences, a biotechnology company with an artificial intelligence/machine learning-guided antibody discovery and development platform, announced its collaboration...
BigHat Biosciences’ Collaboration with Janssen Biotech
BigHat Biosciences’ Research Collaboration with AbbVie
Wilson Sonsini Goodrich & Rosati advised BigHat on the transaction. AbbVie Inc. and BigHat Biosciences announced a research collaboration to discover and develop next-generation therapeutic antibodies...
BigHat’s $75 Million Series B Financing
Gunderson Dettmer represented client Section 32 on the deal while Wilson Sonsini advised BigHat Biosciences. Section 32, a venture capital fund that invests in frontiers of...